1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [37c4e468-626c-4290-affc-ef4b62c22a19] => Array ( [runtime-id] => 37c4e468-626c-4290-affc-ef4b62c22a19 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [1f9872de-19da-4bb2-b573-ae4d32407f4a] => Array ( [runtime-id] => 1f9872de-19da-4bb2-b573-ae4d32407f4a [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;e923f6d04adc0d3726b781100c5113128d0e4618 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [37c4e468-626c-4290-affc-ef4b62c22a19] => Array ( [runtime-id] => 37c4e468-626c-4290-affc-ef4b62c22a19 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [1f9872de-19da-4bb2-b573-ae4d32407f4a] => Array ( [runtime-id] => 1f9872de-19da-4bb2-b573-ae4d32407f4a [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;e923f6d04adc0d3726b781100c5113128d0e4618 ) ) )Table 1:Demographic and clinical information of nasopharyngeal cancer
Clinical Information Demographic Sex Male = 8, female = 4 Median age (range) (yr) 52.5 (36–69) Clinical Pathology Squamous cell carcinoma 12/12 (100.0%) T classification T1 2/12 (16.7%) T2 5/12 (41.7%) T3 2/12 (16.7%) T4 3/12 (25.0%)